Glendon E. French III

CIK: 0001805624

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)18 (90.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (10.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

LUNG

Pulmonx Corp

DirectorOfficer

EDAP

EDAP TMS SA

Director

Discretionary Trading P&L

Holdings

Transaction History (20 total)

LUNG
Pulmonx Corp
Sep 1, 2026
Sale(S)
Direct
37.8K shares at avg. $2.26$85K
LUNG
Pulmonx Corp
Sep 1, 2026
Sale(S)
Direct
4.1K shares at avg. $2.26$9K
LUNG
Pulmonx Corp
Jun 2, 2026
Sale(S)
Direct
13.5K shares at avg. $1.57$21K
LUNG
Pulmonx Corp
Jun 1, 2026
Sale(S)
Direct
4.2K shares at avg. $1.54$6K
LUNG
Pulmonx Corp
Jun 1, 2026
Sale(S)
Direct
38.5K shares at avg. $1.54$59K
LUNG
Pulmonx Corp
Mar 2, 2026
Sale(S)
Direct
58.4K shares at avg. $1.43$83K
LUNG
Pulmonx Corp
Mar 2, 2026
Sale(S)
Direct
6.7K shares at avg. $1.43$10K
LUNG
Pulmonx Corp
Mar 2, 2026
Sale(S)
Direct
2.7K shares at avg. $1.43$4K
LUNG
Pulmonx Corp
Dec 1, 2025
Sale(S)
Direct
6.3K shares at avg. $1.57$10K
LUNG
Pulmonx Corp
Dec 1, 2025
Award(A)
Direct
1.2M shares-
LUNG
Pulmonx Corp
Dec 1, 2025
Sale(S)
Direct
2.5K shares at avg. $1.57$4K
LUNG
Pulmonx Corp
Jun 2, 2025
Award(A)
Direct
37.2K shares-
LUNG
Pulmonx Corp
Mar 20, 2025
Sale(S)
Direct
20K shares at avg. $7.85$157K
LUNG
Pulmonx Corp
Feb 20, 2025
Sale(S)
Direct
12.4K shares at avg. $8.76$109K
LUNG
Pulmonx Corp
Feb 20, 2025
Sale(S)
Direct
43K shares at avg. $8.14$350K
LUNG
Pulmonx Corp
Jan 17, 2025
Sale(S)
Direct
2.2K shares at avg. $6.50$14K
LUNG
Pulmonx Corp
Jan 16, 2025
Sale(S)
Direct
2.3K shares at avg. $6.53$15K
LUNG
Pulmonx Corp
Nov 22, 2024
Sale(S)
Direct
20K shares at avg. $6.63$133K
LUNG
Pulmonx Corp
Oct 17, 2024
Sale(S)
Direct
20K shares at avg. $6.52$130K
LUNG
Pulmonx Corp
Sep 12, 2024
Sale(S)
Direct
20K shares at avg. $8.09$162K

		Type	Shares	Price		Ownership
Sep 1, 2026	LUNG Pulmonx Corp	Sale(S)	37,784	$2.26	$85,392	Direct
Sep 1, 2026	LUNG Pulmonx Corp	Sale(S)	4,098	$2.26	$9,261	Direct
Jun 2, 2026	LUNG Pulmonx Corp	Sale(S)	13,511	$1.57	$21,212	Direct
Jun 1, 2026	LUNG Pulmonx Corp	Sale(S)	4,171	$1.54	$6,423	Direct
Jun 1, 2026	LUNG Pulmonx Corp	Sale(S)	38,467	$1.54	$59,239	Direct
Mar 2, 2026	LUNG Pulmonx Corp	Sale(S)	58,368	$1.43	$83,466	Direct
Mar 2, 2026	LUNG Pulmonx Corp	Sale(S)	6,737	$1.43	$9,634	Direct
Mar 2, 2026	LUNG Pulmonx Corp	Sale(S)	2,708	$1.43	$3,872	Direct
Dec 1, 2025	LUNG Pulmonx Corp	Sale(S)	6,281	$1.57	$9,861	Direct
Dec 1, 2025	LUNG Pulmonx Corp	Award(A)	1,200,000	-	-	Direct
Dec 1, 2025	LUNG Pulmonx Corp	Sale(S)	2,524	$1.57	$3,963	Direct
Jun 2, 2025	LUNG Pulmonx Corp	Award(A)	37,153	-	-	Direct
Mar 20, 2025	LUNG Pulmonx Corp	Sale(S)	20,000	$7.85	$157,000	Direct
Feb 20, 2025	LUNG Pulmonx Corp	Sale(S)	12,417	$8.76	$108,773	Direct
Feb 20, 2025	LUNG Pulmonx Corp	Sale(S)	43,036	$8.14	$350,313	Direct
Jan 17, 2025	LUNG Pulmonx Corp	Sale(S)	2,221	$6.50	$14,437	Direct
Jan 16, 2025	LUNG Pulmonx Corp	Sale(S)	2,326	$6.53	$15,189	Direct
Nov 22, 2024	LUNG Pulmonx Corp	Sale(S)	20,000	$6.63	$132,600	Direct
Oct 17, 2024	LUNG Pulmonx Corp	Sale(S)	20,000	$6.52	$130,400	Direct
Sep 12, 2024	LUNG Pulmonx Corp	Sale(S)	20,000	$8.09	$161,800	Direct

1-20 of 20 transactions

About French Glendon E. III

French Glendon E. III (SEC CIK 0001805624) files insider reports with the SEC as President and CEO of Pulmonx Corp (LUNG) and Director of EDAP TMS SA (EDAP).

Signal8 holds 12 ownership filings by French Glendon E. III (1 Form 3, 11 Form 4), filed between Sep 18, 2024 and Sep 3, 2026. Those filings report 20 transactions, from Sep 12, 2024 to Sep 1, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on French Glendon E. III's filings is in REDWOOD CITY, CA.

Recent filings by French Glendon E. III

Sep 1, 2026: Open-market sales of LUNG shares (2 lines, Form 4, code S).
Jun 2, 2026: Open-market sale of LUNG shares (Form 4, code S).
Jun 1, 2026: Open-market sales of LUNG shares (2 lines, Form 4, code S).
Mar 2, 2026: Open-market sales of LUNG shares (3 lines, Form 4, code S).
Dec 1, 2025: Open-market sale of LUNG shares (Form 4, code S).

Other insiders filing for Pulmonx Corp (LUNG)

Radhakrishnan Srikanth, Chief Science & Techn. Officer
Lehman David Aaron, General Counsel
Rose Geoffrey Beran, Chief Commercial Officer
Burns Thomas William, Director
Ferrari Richard, Director
Florin Daniel P, Director

How to read Form 4 transaction codes